Orn8, Urotensin II, human contains an ornithine substitution that modifies electrostatic and conformational properties. The disulfide-stabilized cyclic framework remains central to structural behavior. Its unique residue composition supports comparative binding analysis. Research uses include folding studies, ligand-receptor evaluations, and peptide engineering.
CAT No: U03010
2. TMEM16F and dynamins control expansive plasma membrane reservoirs
3. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
5. The spatiotemporal control of signalling and trafficking of the GLP-1R
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More